Delivery Order SPE2DR25D1106-SPE2DR26FJG7E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,986.63 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Exforge 5-160 mg tablets (30-count). The contract utilizes firm fixed pricing with a completion date of January 6, 2026, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,145.66 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement. The place of performance is listed as Conshohocken, Pennsylvania, which coincides with AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.79 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The Defense Logistics Agency awarded a delivery order valued at $2,525.28 to AmerisourceBergen Drug Corp on May 28, 2025, for the supply of Exforge 5-160 mg tablets (30-count unit). This firm fixed-price contract, with a completion date of May 29, 2025, represents a routine pharmaceutical procurement executed through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency awarded a delivery order valued at $5,524.91 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) on June 25, 2025, with completion targeted for June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.67 to AmerisourceBergen Drug Corp for the supply of Exforge 5-160 mg tablets (30-count units) under a firm fixed price contract. The award, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $6,588.62 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count units). This firm fixed price delivery order, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,085.02 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Exforge 10-160 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by May 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-160 mg tablets (30-count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $1,230.19 and utilizes firm fixed price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Exforge 10-160 mg tablets (30-count units) with a ceiling value of $4,993.49. This firm fixed-price delivery order, which is not set-aside and will be completed by July 24, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJG7EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,034.97 to Amerisourcebergen Drug Corp on January 7, 2026, for the supply of Exforge 5-160 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of January 8, 2026, and performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value extending through December 2026. This prime contract vehicle enables comprehensive global pharmaceutical support across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies for military treatment facilities and other federal healthcare programs. The non-set-aside competitive award reflects the contractor's proven capability to meet federal procurement requirements in the pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 1/6/26 |